Skip to Content
You are currently on the new version of our website. Access the old version .

International Journal of Translational Medicine, Volume 3, Issue 2

2023 June - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Review
  • Open Access
2 Citations
5,678 Views
19 Pages

Insights into COVID-19 and Its Potential Implications for Kidney Dysfunction

  • Adel Abdel-Moneim,
  • Eman H. Bakry and
  • Mohamed Y. Zaky

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a significant impact on the world’s demographics, resulting in over 6 million deaths globally. COVID-19 has been associated...

(This article belongs to the Special Issue Translational Medicine Approach against the COVID-19 Pandemic 2.0)
  • Article
  • Open Access
2 Citations
3,801 Views
9 Pages

Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia

  • Francesco Bruno,
  • Paolo Abondio,
  • Valentina Laganà,
  • Rosanna Colao and ,
  • Sabrina M. Curcio,
  • Francesca Frangipane,
  • Gianfranco Puccio,
  • Raffaele Di Lorenzo,
  • Amalia C. Bruni and
  • Raffaele Maletta
  • + 5 authors+ 0 author

Older adults with dementia present an increased risk of mortality due to seasonal influenza. Despite concerning evidence, the influenza vaccination program has been unsuccessful, with low rates of uptake in Italian people ≥65 years. In addition, b...

(This article belongs to the Special Issue Translational Aspects of Infectious Diseases: From Bench to Bedside 2.0)
  • Review
  • Open Access
6 Citations
7,876 Views
29 Pages

A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022)

  • Viren Soni,
  • Akhil Nagar,
  • Ruchita Bardiya,
  • Jacob Mara and ,
  • Lukas Von Suskil,
  • Sabrina Rose and
  • Chetankumar Sonawane
  • + 2 authors+ 0 author

Cancer stem cells (CSCs) are the cells in a primary tumor that have the opportunity to self-renew as well as differentiate into certain cell types, thus forming a mixed tumor. CSCs have been shown to be involved in every aspect of cancer development,...

(This article belongs to the Special Issue Trends of Translational Medicine for Oncology)
  • Review
  • Open Access
5 Citations
4,907 Views
14 Pages

Analogies between COVID-19 and Preeclampsia: Focus on Therapies

  • Valentina Giardini,
  • Carlo Gambacorti-Passerini,
  • Marco Casati,
  • Andrea Carrer and
  • Patrizia Vergani

Preeclampsia is an obstetric pathology with striking similarities to COVID-19. The renin-angiotensin system plays a key role in the pathogenesis of both diseases. This report reviews the pharmacological strategies that have been suggested for the pre...

(This article belongs to the Special Issue Translational Medicine Approach against the COVID-19 Pandemic 2.0)
  • Review
  • Open Access
14 Citations
8,148 Views
16 Pages

Malaria and HIV are geographically in the tropics and subtropics of the world, including sub-Saharan Africa. Understanding the overlapping effect of both infections, especially among pregnant women, is crucial in managing pregnant women during antena...

(This article belongs to the Special Issue Translational Aspects of Infectious Diseases: From Bench to Bedside 2.0)
  • Comment
  • Open Access
5 Citations
2,576 Views
4 Pages

Toxicological Potential of the FDA-Approved Treatment against Monkeypox. Comment on Zovi et al. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. Int. J. Mol. Sci. 2022, 23, 15941

  • Gabriel Christian de Farias Morais,
  • Umberto Laino Fulco,
  • Edilson Dantas da Silva,
  • Claudio Bruno Silva de Oliveira and
  • Jonas Ivan Nobre Oliveira

Recently, some drugs were approved to control Monkeypox (MPX), among them tecovirimat. This was recently approved by regulatory agencies around the world, the paper of Zovi et al entitled Pharmacological Agents with Antiviral Activity against Monkeyp...

(This article belongs to the Special Issue Translational Aspects of Infectious Diseases: From Bench to Bedside 2.0)
XFacebookLinkedIn
Int. J. Transl. Med. - ISSN 2673-8937